Related Experiment Videos
Urokinase therapy in mesenteric venous thrombosis: a case study
Summary
Mesenteric venous thrombosis, a serious condition, can be treated with urokinase infusion via a femoral catheter. This approach offers a potential alternative to surgery, improving survival rates for this rare emergency.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Gastroenterology
Background:
- Mesenteric venous thrombosis (MVT) is a rare but life-threatening condition often requiring surgical intervention.
- Current treatments for MVT, including bowel resection and anticoagulation, have limited success rates.
- Exploring novel, less invasive treatment modalities for MVT is crucial.
Observation:
- A case of an 18-year-old male patient with MVT is presented.
- The patient was successfully treated using a minimally invasive approach.
- A femoral infusion catheter was placed in the superior mesenteric artery for urokinase administration.
Findings:
- Continuous infusion of urokinase directly into the superior mesenteric artery led to successful treatment of MVT.
- This interventional radiology technique avoided the need for extensive bowel resection.
- The patient experienced a positive outcome, highlighting the efficacy of this treatment.
Implications:
- This case suggests that intra-arterial urokinase infusion is a viable alternative treatment for MVT.
- It offers a less invasive option compared to traditional surgical management.
- Further research and case studies are warranted to establish this technique as a standard MVT treatment, emphasizing nursing care considerations.